Evidence map›Paper›PMID 17360652›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion.

Martin Rowe, Britt Glaunsinger, Daphne van Leeuwen, Jianmin Zuo, David Sweetman, Don Ganem, Jaap Middeldorp, Emmanuel J H J Wiertz, Maaike E Ressing

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 1 synthesis or guideline pooled it, 240 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Epstein-Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Martin RoweDivision of Cancer Studies, University of Birmingham Medical School, Vincent Drive, Edgbaston, Birmingham B15 2TT, United Kingdom.
Britt Glaunsinger
Daphne van Leeuwen
Jianmin Zuo
David Sweetman
Don Ganem
Jaap Middeldorp
Emmanuel J H J Wiertz
Maaike E Ressing
Leiden University Medical Center · NLUniversity of Birmingham · GBHoward Hughes Medical Institute · USUniversity of California, San Francisco · US

Funding

Wellcome TrustWellcome Trust GR072425
6 · The paper itself

Abstract

Relatively little is known about immune evasion during the productive phase of infection by the gamma(1)-herpesvirus Epstein-Barr virus (EBV). The use of a unique system to isolate cells in lytic cycle allowed us to identify a host shutoff function operating in productively EBV-infected B cells. This impairment of protein synthesis results from mRNA degradation induced upon expression of the early lytic-cycle gene product BGLF5. Recently, a gamma(2)-herpesvirus, Kaposi sarcoma herpesvirus, has also been shown to encode a host shutoff function, indicating that host shutoff appears to be a general feature of gamma-herpesviruses. One of the consequences of host shutoff is a block in the synthesis of HLA class I and II molecules, reflected by reduced levels of these antigen-presenting complexes at the surface of cells in EBV lytic cycle. This effect could lead to escape from T cell recognition and elimination of EBV-producing cells, thereby allowing generation of viral progeny in the face of memory T cell responses.

Indexed as

Antigen PresentationB-LymphocytesCell Line, TumorDeoxyribonucleasesEpstein-Barr Virus InfectionsGene Expression RegulationHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansMicroscopy, FluorescenceProtein BiosynthesisViral Proteinsdeoxyribonuclease, Epstein-Barr virusDeoxyribonucleasesHistocompatibility Antigens Class IHistocompatibility Antigens Class IIViral Proteins

Identifiers

PMID17360652
PMCPMC1805610
OpenAlexW2021743722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.